Wegovy maker Novo's profit warning wipes out $70B in market value after shares plunge 30%
1. Novo Nordisk lost $70 billion after a profit warning. 2. New CEO Maziar Mike Doustdar aims to revive sales. 3. 2025 sales growth outlook cut from 13%-21% to 8%-14%. 4. Wegovy faces competition, leading to significant market impact. 5. Prescriptions for Zepbound are now surpassing those for Wegovy.